to reduce the chance of big cardiovascular occasions for instance heart assault, stroke, or Dying in Older people with kind two diabetes with identified heart problems.Presently, the FDA has only supplied acceptance to Wegovy, two.4 mg, subcutaneous semaglutide, as an antiobesity medication.seven Sooner or later, it could be helpful to investigate